WO2019027239A3 - Composition for preventing hair loss or promoting hair growth - Google Patents

Composition for preventing hair loss or promoting hair growth Download PDF

Info

Publication number
WO2019027239A3
WO2019027239A3 PCT/KR2018/008710 KR2018008710W WO2019027239A3 WO 2019027239 A3 WO2019027239 A3 WO 2019027239A3 KR 2018008710 W KR2018008710 W KR 2018008710W WO 2019027239 A3 WO2019027239 A3 WO 2019027239A3
Authority
WO
WIPO (PCT)
Prior art keywords
extract
composition
daniellii
quercitrin
evodia
Prior art date
Application number
PCT/KR2018/008710
Other languages
French (fr)
Korean (ko)
Other versions
WO2019027239A2 (en
Inventor
최강열
심지용
류영찬
박지연
Original Assignee
주식회사 씨케이바이오텍
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020180087096A external-priority patent/KR102112736B1/en
Application filed by 주식회사 씨케이바이오텍 filed Critical 주식회사 씨케이바이오텍
Priority to US16/635,275 priority Critical patent/US11154566B2/en
Priority to EP18840790.2A priority patent/EP3662891B1/en
Priority to CN201880060269.5A priority patent/CN111093620B/en
Publication of WO2019027239A2 publication Critical patent/WO2019027239A2/en
Publication of WO2019027239A3 publication Critical patent/WO2019027239A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth

Abstract

The present invention relates to a composition for preventing hair loss or promoting hair growth, the composition comprising: an indirubin derivative; and at least one selected from the group consisting of an Evodia daniellii extract, a Persicaria hydropiper extract, a Hovenia dulcis extract, methyl vanilate, hesperidin, and quercitrin. Furthermore, the at least one selected from the group consisting of an Evodia daniellii extract, a Persicaria hydropiper extract, a Hovenia dulcis extract, methyl vanilate, hesperidin, and quercitrin of the present invention is a natural substance-derived composition and has little toxicity to cells, and the indirubin derivative is a stable compound that has been found to have little toxicity to the human body, so that, unlike a conventional steroid drug, the use thereof as a mixture has an advantage of not showing side effects on the human body.
PCT/KR2018/008710 2017-08-01 2018-07-31 Composition for preventing hair loss or promoting hair growth WO2019027239A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US16/635,275 US11154566B2 (en) 2017-08-01 2018-07-31 Composition for preventing hair loss or promoting hair growth
EP18840790.2A EP3662891B1 (en) 2017-08-01 2018-07-31 Composition for preventing hair loss or promoting hair growth
CN201880060269.5A CN111093620B (en) 2017-08-01 2018-07-31 Composition for preventing hair loss or promoting hair growth

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
KR10-2017-0097539 2017-08-01
KR20170097539 2017-08-01
KR1020180087096A KR102112736B1 (en) 2017-08-01 2018-07-26 composition for preventing of hair loss or promoting hair growth
KR10-2018-0087096 2018-07-26

Publications (2)

Publication Number Publication Date
WO2019027239A2 WO2019027239A2 (en) 2019-02-07
WO2019027239A3 true WO2019027239A3 (en) 2019-03-28

Family

ID=65234050

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2018/008710 WO2019027239A2 (en) 2017-08-01 2018-07-31 Composition for preventing hair loss or promoting hair growth

Country Status (1)

Country Link
WO (1) WO2019027239A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4010337A4 (en) * 2019-11-04 2023-08-23 CK Regeon Inc. Compositions and methods for suppressing and/or treating neurodegenerative diseases and/or a clinical condition thereof
CN113425636B (en) * 2021-05-21 2023-01-31 广州德谷个人护理用品有限公司 Preparation method of tea bran flavone and application of tea bran flavone in anti-hair loss product

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110130711A1 (en) * 2009-11-19 2011-06-02 Follica, Inc. Hair growth treatment
WO2015005603A1 (en) * 2013-07-11 2015-01-15 Industry-Academic Cooperation Foundation, Yonsei University Small molecule, indirubin-3-oxime, for prevention and treatment of bone disease
JP2016539987A (en) * 2013-12-13 2016-12-22 レスターシー エルエルシイＲｅｓｔｏｒｓｅａ， Ｌｌｃ Exfoliating hair retention promoting formulation
KR20170030175A (en) * 2015-09-09 2017-03-17 강원대학교산학협력단 Ready-to-use adjuvant composition for intranasal immunization based on microemulsion

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101168051B1 (en) 2008-09-08 2012-07-24 김우경 Pharmaceutical Compositions for Treating or Preventing Ophthalmic or Skin Disease Comprising Curcumin as an Active Ingredient

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110130711A1 (en) * 2009-11-19 2011-06-02 Follica, Inc. Hair growth treatment
WO2015005603A1 (en) * 2013-07-11 2015-01-15 Industry-Academic Cooperation Foundation, Yonsei University Small molecule, indirubin-3-oxime, for prevention and treatment of bone disease
JP2016539987A (en) * 2013-12-13 2016-12-22 レスターシー エルエルシイＲｅｓｔｏｒｓｅａ， Ｌｌｃ Exfoliating hair retention promoting formulation
KR20170030175A (en) * 2015-09-09 2017-03-17 강원대학교산학협력단 Ready-to-use adjuvant composition for intranasal immunization based on microemulsion

Also Published As

Publication number Publication date
WO2019027239A2 (en) 2019-02-07

Similar Documents

Publication Publication Date Title
MX2021000887A (en) Heterocyclic spiro compounds and methods of use thereof for the treatment of cancer.
MX2019013954A (en) Covalent inhibitors of kras.
MX2021005924A (en) Compounds and methods of use thereof for treatment of cancer.
MX2018000777A (en) Substituted quinazoline compounds and their use as inhibitors of g12c mutant kras, hras and/or nras proteins.
EA201891191A1 (en) 2-SUBSTITUTED HINAZOLIN COMPOUNDS CONTAINING A SUBSTITUTED HETEROCYCLIC GROUP AND METHODS OF THEIR APPLICATION
MX2021015708A (en) Compounds for treatment of pd-l1 diseases.
PH12021551256A1 (en) Pantetheine derivatives and uses thereof
MX2021009854A (en) Novel heterotricyclic derivative compound and use of same.
AU2018253590A1 (en) Imidazopyridazine compounds
EP4249071A3 (en) Benzoazepine analogs as inhibiting agents for bruton's tyrosine kinase
AU2024202522A1 (en) Crystalline forms of 3-substituted 1,2,4-oxadiazole
WO2018201167A3 (en) Propionic acid derivatives and methods of use thereof
MX2019013561A (en) Pyrrolopyridine-aniline compounds for treatment of dermal disorders.
WO2018143552A3 (en) Injectable composition for preventing hair loss or stimulating hair growth
MX2020005942A (en) Oral thin film with high active agent loading.
MX2021015543A (en) Pyrimidine derivative inhibiting growth of cancer cell and medicinal use thereof.
SA520411635B1 (en) Fused Ring Derivative as A2A Receptor Inhibitor
MX2020011986A (en) Compositions comprising glucose and hemicellulose and their use.
CR20220216A (en) Heteroaryl-biphenyl amines for the treatment of pd-l1 diseases
CR20220160A (en) Azole-fused pyridazin-3(2h)-one derivatives
WO2019027239A3 (en) Composition for preventing hair loss or promoting hair growth
BR112021011325A2 (en) Rapamycin derivatives
MX2021012105A (en) Pyrrole compounds.
MX2020011453A (en) Combinations for treating cancer.
PH12021550617A1 (en) Cyclic dinucleotide analogue, pharmaceutical composition thereof, and application

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 18840790

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2018840790

Country of ref document: EP

Effective date: 20200302